PTC Therapeutics
PTC Therapeutics (PTC), formerly Agilis Biotherapeutics, is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders.

Year Established: 1998
Stock Ticker: NASDAQ
Exchange: PTCT